{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:46:36Z","timestamp":1787161596162,"version":"build-2736575974"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02283-w","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:47:16Z","timestamp":1780501636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Measles challenges: global resurgence and factors affecting eradication"],"prefix":"10.1186","volume":"52","author":[{"given":"Eltayib H. Ahmed","family":"Mohamedosman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Fahad","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-793X","authenticated-orcid":false,"given":"Tarig M. S.","family":"Alnour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmutuz H.","family":"Elssaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadil","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8802-7489","authenticated-orcid":false,"given":"Mohamed I.","family":"Holie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2283_CR1","doi-asserted-by":"publisher","first-page":"1491927","DOI":"10.3389\/fpubh.2024.1491927","volume":"12","author":"IM Tahir","year":"2024","unstructured":"Tahir IM, Kumar V, Faisal H, Gill A, Kumari V, Tahir HM, Haque MA. Contagion comeback: unravelling the measles outbreak across the USA. Front Public Health. 2024;12:1491927.","journal-title":"Front Public Health"},{"issue":"7","key":"2283_CR2","doi-asserted-by":"publisher","first-page":"e18095","DOI":"10.1016\/j.heliyon.2023.e18095","volume":"9","author":"JE Libbey","year":"2023","unstructured":"Libbey JE, Fujinami RS, Morbillivirus. A highly adaptable viral genus. Heliyon. 2023;9(7):e18095.","journal-title":"Heliyon"},{"key":"2283_CR3","doi-asserted-by":"publisher","first-page":"16049","DOI":"10.1038\/nrdp.2016.49","volume":"2","author":"P Rota","year":"2016","unstructured":"Rota P, Moss W, Takeda M, et al. Measles Nat Rev Dis Primers. 2016;2:16049.","journal-title":"Measles Nat Rev Dis Primers"},{"key":"2283_CR4","doi-asserted-by":"crossref","unstructured":"Moss WJ, Griffin DE, Feinstone W. WH. Measles; Editor(s): Alan D.T. Barrett, Lawrence R. Stanberry. Vaccines for biodefense and emerging and neglected diseases. Academic Press. 2009;551\u2013565.","DOI":"10.1016\/B978-0-12-369408-9.00030-5"},{"issue":"3","key":"2283_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jinf.2021.07.011","volume":"83","author":"R Jaafar","year":"2021","unstructured":"Jaafar R, Zandotti C, Grimaldier C, Etoundi M, Kadri I, Boschi C, Jardot P, Colson P, Raoult D, La Scola B, Aherfi S. Epidemiological and genetic characterization of measles virus circulating strains at Marseille, France during 2017\u20132019 measles outbreak. J Infect. 2021;83(3):361\u201370.","journal-title":"J Infect"},{"issue":"6497","key":"2283_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1126\/science.aba9411","volume":"368","author":"A D\u00fcx","year":"2020","unstructured":"D\u00fcx A, Lequime S, Patrono LV, Vrancken B, Boral S, Gogarten JF, Hilbig A, Horst D, Merkel K, Prepoint B, Santibanez S, Schlotterbeck J, Suchard MA, Ulrich M, Widulin N, Mankertz A, Leendertz FH, Harper K, Schnalke T, Lemey P, Calvignac-Spencer S. Measles virus and rinderpest virus divergence dated to the sixth century BCE. Science. 2020;368(6497):1367\u201370.","journal-title":"Science"},{"issue":"8","key":"2283_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/14760584.2015.1055325","volume":"14","author":"ML Avila-Aguero","year":"2015","unstructured":"Avila-Aguero ML, Camacho-Badilla K, Ulloa-Gutierrez R. Measles outbreaks: what does it represent for the elimination strategy in the region of the Americas? A call for the action. Expert Rev Vaccines. 2015;14(8):1043\u20135.","journal-title":"Expert Rev Vaccines"},{"key":"2283_CR8","doi-asserted-by":"publisher","first-page":"107189","DOI":"10.1016\/j.ijid.2024.107189","volume":"147","author":"S Bidari","year":"2024","unstructured":"Bidari S, Yang W. Global resurgence of measles in the vaccination era and influencing factors. Int J Infect Dis. 2024;147:107189.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"2283_CR9","doi-asserted-by":"publisher","first-page":"NP2749","DOI":"10.1177\/1010539512466567","volume":"27","author":"AR Khowaja","year":"2015","unstructured":"Khowaja AR, Sheikh S, Saleem AF, Zaidi AK. Parental awareness and coverage of mass measles vaccination drive 2011: cross-sectional survey in the metropolitan city of Karachi, Pakistan. Asia Pac J Public Health. 2015;27(2):NP2749\u201356.","journal-title":"Asia Pac J Public Health"},{"issue":"2","key":"2283_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/vaccines13020157","volume":"13","author":"P Plans-Rubi\u00f3","year":"2025","unstructured":"Plans-Rubi\u00f3 P. Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023. Vaccines (Basel). 2025;13(2):157.","journal-title":"Vaccines (Basel)"},{"key":"2283_CR11","unstructured":"WHO Regional Office for Europe. European Region reports highest number of measles cases in more than 25 years \u2013 UNICEF, WHO\/Europe. 13 Mar 2025."},{"key":"2283_CR12","doi-asserted-by":"crossref","unstructured":"European Centre for Disease Prevention and Control (ECDC). Measles \u2013 annual epidemiological report for 2024. 28 Apr 2025.","DOI":"10.2807\/1560-7917.ES.2023.28.2.2301121"},{"key":"2283_CR13","unstructured":"WHO Regional Office for Africa (WHO AFRO). MEASLES: WHO AFRO Report (provisional data; updates March 2025). (Jan 2024\u2013Feb 2025 window shown in report)."},{"issue":"1","key":"2283_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0891-5520(03)00091-6","volume":"18","author":"BA Cunha","year":"2004","unstructured":"Cunha BA. Smallpox and measles: historical aspects and clinical differentiation. Infect Dis Clin North Am. 2004;18(1):79\u2013100.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"2283_CR15","doi-asserted-by":"publisher","first-page":"104149","DOI":"10.1016\/j.lpm.2022.104149","volume":"51","author":"P Berche","year":"2022","unstructured":"Berche P. History of measles. Presse Med. 2022;51(3):104149.","journal-title":"Presse Med"},{"issue":"2","key":"2283_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/1995-705X.115499","volume":"14","author":"R Hajar","year":"2013","unstructured":"Hajar R. The Air of History (Part IV): Great Muslim Physicians Al Rhazes. Heart Views. 2013;14(2):93\u20135.","journal-title":"Heart Views"},{"key":"2283_CR17","unstructured":"Thomas Sydenham. Processus Integri in Morbis Fer\u00e8 Omnibus Curandis, 5th edn (London, 1726)."},{"key":"2283_CR18","unstructured":"Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors. Adverse effects of vaccines: evidence and causality. Washington (DC): National Academies Press (US) et al. 2011 Aug 25. 4, Measles, Mumps, and Rubella Vaccine. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK190025\/."},{"issue":"1","key":"2283_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/21645515.2018.1517074","volume":"15","author":"DTS Hayman","year":"2019","unstructured":"Hayman DTS. Measles vaccination in an increasingly immunized and developed world. Hum Vaccin Immunother. 2019;15(1):28\u201333.","journal-title":"Hum Vaccin Immunother"},{"key":"2283_CR20","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fmicb.2020.01526","volume":"11","author":"CMC Rodrigues","year":"2020","unstructured":"Rodrigues CMC, Plotkin SA. Impact of Vaccines; Health, Economic and Social Perspectives. Front Microbiol. 2020;11:1526.","journal-title":"Front Microbiol"},{"key":"2283_CR21","doi-asserted-by":"publisher","unstructured":"Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, H\u00fcbschen JM, Siqueira M, Beirnes J, Ahmed H, Triki H, Al-Busaidy S, Dosseh A, Byabamazima C, Smit S, Akoua-Koffi C, Bwogi J, Bukenya H, Wairagkar N, Ramamurty N, Incomserb P, Pattamadilok S, Jee Y, Lim W, Xu W, Komase K, Takeda M, Tran T, Castillo-Solorzano C, Chenoweth P, Brown D, Mulders MN, Bellini WJ, Featherstone D. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011;204 Suppl 1:S514-23. https:\/\/doi.org\/10.1093\/infdis\/jir118. PMID: 21666208.","DOI":"10.1093\/infdis\/jir118"},{"issue":"7","key":"2283_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/vaccines12070810","volume":"12","author":"B Bankamp","year":"2024","unstructured":"Bankamp B, Kim G, Hart D, Beck A, Ben Mamou M, Penedos A, Zhang Y, Evans R, Rota PA. Global Update on Measles Molecular Epidemiology. Vaccines (Basel). 2024;12(7):810. https:\/\/doi.org\/10.3390\/vaccines12070810. PMID: 39066448; PMCID: PMC11281501.","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"2283_CR23","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/cid\/cix974","volume":"66","author":"SF Ackley","year":"2018","unstructured":"Ackley SF, Hacker JK, Enanoria WTA, Worden L, Blumberg S, Porco TC, Zipprich J. Genotype-Specific Measles Transmissibility: A Branching Process Analysis. Clin Infect Dis. 2018;66(8):1270\u20135. https:\/\/doi.org\/10.1093\/cid\/cix974. PMID: 29228134; PMCID: PMC5889020.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2283_CR24","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","volume":"17","author":"FM Guerra","year":"2017","unstructured":"Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420\u20138.","journal-title":"Lancet Infect Dis"},{"key":"2283_CR25","doi-asserted-by":"publisher","unstructured":"Oliveira SA, Camacho LA, Pereira AC, Set\u00fabal S, Nogueira RM, Siqueira MM. Assessment of the performance of a definition of a suspected measles case: implications for measles surveillance. Rev Panam Salud Publica. 2006;19(4):229\u2009\u2013\u200935. https:\/\/doi.org\/10.1590\/s1020-49892006000400002. PMID: 16723063.","DOI":"10.1590\/s1020-49892006000400002"},{"issue":"2","key":"2283_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/microorganisms8020276","volume":"8","author":"A Misin","year":"2020","unstructured":"Misin A, Antonello RM, Di Bella S, Campisciano G, Zanotta N, Giacobbe DR, Comar M, Luzzati R. Measles: An Overview of a Re-Emerging Disease in Children and Immunocompromised Patients. Microorganisms. 2020;8(2):276.","journal-title":"Microorganisms"},{"issue":"5","key":"2283_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1503\/cmaj.080724","volume":"180","author":"O Steichen","year":"2009","unstructured":"Steichen O, Dautheville S. Koplik spots in early measles. CMAJ. 2009;180(5):583.","journal-title":"CMAJ"},{"issue":"2","key":"2283_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/GRF.0b013e31824df256","volume":"55","author":"SJ White","year":"2012","unstructured":"White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM. Measles, mumps, and rubella. Clin Obstet Gynecol. 2012;55(2):550\u20139.","journal-title":"Clin Obstet Gynecol"},{"key":"2283_CR29","unstructured":"WHO Vaccine-Preventable Diseases Surveillance Standards. https:\/\/www.source\/immunization\/vpd_surveillance\/vpd-surveillance-standards-publication\/who-surveillancevaccinepreventable-11-measles-r2.pdf. Accessed on 23.12.2025."},{"key":"2283_CR30","doi-asserted-by":"publisher","unstructured":"Hutchins SS, Papania MJ, Amler R, Maes EF, Grabowsky M, Bromberg K, Glasglow V, Speed T, Bellini WJ, Orenstein WA. Evaluation of the measles clinical case definition. J Infect Dis. 2004;189 Suppl 1:S153-9. https:\/\/doi.org\/10.1086\/379652. PMID: 15106104.","DOI":"10.1086\/379652"},{"issue":"1","key":"2283_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12887-020-1908-6","volume":"20","author":"D Husada","year":"2020","unstructured":"Husada D, Kusdwijono, Puspitasari D, Kartina L, Basuki PS. Ismoedijanto. An evaluation of the clinical features of measles virus infection for diagnosis in children within a limited resources setting. BMC Pediatr. 2020;20(1):5. https:\/\/doi.org\/10.1186\/s12887-020-1908-6. PMID: 31906914; PMCID: PMC6943953.","journal-title":"BMC Pediatr"},{"issue":"9","key":"2283_CR32","first-page":"e01938","volume":"58","author":"MM Azar","year":"2020","unstructured":"Azar MM, Canterino J, Landry ML. The brief case: secondary measles and the pitfalls of diagnostic testing. J Clin Microbiol. 2020;58(9):e01938\u201319.","journal-title":"J Clin Microbiol"},{"key":"2283_CR33","unstructured":"Coetzee S, Morrow BM, Argent AC. Measles in a South African paediatric intensive care unit: again! J Paediatr Child Health., Ciampi G, Spicuzza L. Severe and fatal measles-associated pneumonia during an outbreak in Italy: data from the heart of the epidemic. Adv Respir Med."},{"issue":"12","key":"2283_CR34","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3390\/v14122641","volume":"14","author":"L Amurri","year":"2022","unstructured":"Amurri L, Reynard O, Gerlier D, Horvat B, Iampietro M. Measles Virus-Induced Host Immunity and Mechanisms of Viral Evasion. Viruses. 2022;14(12):2641. https:\/\/doi.org\/10.3390\/v14122641. PMID: 36560645; PMCID: PMC9781438.","journal-title":"Viruses"},{"issue":"1","key":"2283_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13052-025-01989-7","volume":"51","author":"M Ari","year":"2025","unstructured":"Ari M, Ari HF, Cengiz H. Advanced biomarkers for prognostic evaluation of pneumonia severity in pediatric intensive care: focus on novel inflammatory and hematological ratios. Ital J Pediatr. 2025;51(1):168. https:\/\/doi.org\/10.1186\/s13052-025-01989-7. PMID: 40457390; PMCID: PMC12131600.","journal-title":"Ital J Pediatr"},{"key":"2283_CR36","doi-asserted-by":"publisher","unstructured":"Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1;189 Suppl 1:S4-16.PMID: 15106083 https:\/\/doi.org\/10.1086\/377712","DOI":"10.1086\/377712"},{"key":"2283_CR37","doi-asserted-by":"publisher","unstructured":"Seo E, Chang YJ, Woo Chung J, Chung YS, Yeon Park S. Detection of measles vaccine virus and measles-specific immunoglobulin M in children vaccinated against measles-mumps-rubella during measles outbreak. Vaccine X. 2024 Apr 24;18:100491. https:\/\/doi.org\/10.1016\/j.jvacx","DOI":"10.1016\/j.jvacx"},{"issue":"48","key":"2283_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.15585\/mmwr.mm6848a1","volume":"68","author":"MK Patel","year":"2019","unstructured":"Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, Kretsinger K, McFarland J, Rota PA, Goodson JL. Progress Toward Regional Measles Elimination - Worldwide, 2000\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68(48):1105\u201311.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2283_CR39","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S1473-3099(20)30522-3","volume":"20","author":"L Gardner","year":"2020","unstructured":"Gardner L, Dong E, Khan K, Sarkar S. Persistence of US measles risk due to vaccine hesitancy and outbreaks abroad. Lancet Infect Dis. 2020;20(10):1114\u20135.","journal-title":"Lancet Infect Dis"},{"key":"2283_CR40","doi-asserted-by":"publisher","first-page":"m4450","DOI":"10.1136\/bmj.m4450","volume":"371","author":"JH Tanne","year":"2020","unstructured":"Tanne JH. Measles cases and deaths are increasing worldwide, warn health agencies. BMJ. 2020;371:m4450.","journal-title":"BMJ"},{"key":"2283_CR41","doi-asserted-by":"crossref","unstructured":"Anderer S. Global measles cases rose 20% in 1 year as vaccine coverage fell short. JAMA. 2024.","DOI":"10.1001\/jama.2024.25514"},{"issue":"34","key":"2283_CR42","first-page":"1432","volume":"17","author":"u-Young Sim","year":"2024","unstructured":"Sim u-Young, Chung J-H, Oh J-Y, Yi J-E, Lee Y-H, Choi S-W, Lee J-A, Jin Y-W. Global Measles Outbreaks Public Health Wkly Rep. 2024;17(34):1432\u201348. Hyo-Soon Yoo*.","journal-title":"Global Measles Outbreaks Public Health Wkly Rep"},{"issue":"2","key":"2283_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/idr16020028","volume":"16","author":"F Branda","year":"2024","unstructured":"Branda F, Giovanetti M, Romano C, Benvenuto D, Ciccozzi A, Sanna D, Ciccozzi M, Scarpa F. Global Measles Surveillance: Trends, Challenges, and Implications for Public Health Interventions. Infect Dis Rep. 2024;16(2):367\u201379.","journal-title":"Infect Dis Rep"},{"key":"2283_CR44","doi-asserted-by":"publisher","first-page":"102502","DOI":"10.1016\/j.eclinm.2024.102502","volume":"68","author":"Editorial","year":"2024","unstructured":"Editorial. Concerning global rise in measles cases. EClinicalMedicine. 2024;68:102502.","journal-title":"EClinicalMedicine"},{"key":"2283_CR45","unstructured":"Report. https:\/\/www.dshs.texas.gov\/news-alerts\/texas-announces-first-death-measles-outbreak. Accessed on June 1, 2025."},{"key":"2283_CR46","unstructured":"WHO, Measles. number of reported cases. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/measles---number-of-reported-cases. Accessed on June 16, 2025."},{"key":"2283_CR47","unstructured":"WHO. Measles \u2013 Region of the Americas https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON565. Accessed on June 16, 2025."},{"key":"2283_CR48","unstructured":"WHO. Immunization analysis and insights. Provisional monthly measles and rubella data. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/surveillance\/monitoring\/provisional-monthly-measles-and-rubella-data?utm_source=chatgpt.comaccessed on 23.12.2025."},{"key":"2283_CR49","unstructured":"WHO. Immunization data. Reported cases and incidence. https:\/\/immunizationdata.who.int\/global?topic=&location=. Accessed on 12.12.2025."},{"key":"2283_CR50","unstructured":"WHO. Disease Outbreak News Measles \u2013 Morocco. 13. May 2025. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON568?utm_source=chatgpt.com. Accessed on 23.12.2025."},{"key":"2283_CR51","unstructured":"CDC. Measles (Rubeola). Measles symptoms and complications. https:\/\/www.cdc.gov\/measles\/signs-symptoms\/index.html?utm_source=chatgpt.com. Accessed on 23.12.2025."},{"key":"2283_CR52","doi-asserted-by":"publisher","unstructured":"Petrova VN, Sawatsky B, Han AX, Laksono BM, Walz L, Parker E, Pieper K, Anderson CA, de Vries RD, Lanzavecchia A, Kellam P, von Messling V, de Swart RL, Russell CA. Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles. Sci Immunol. 2019;4(41):eaay6125. https:\/\/doi.org\/10.1126\/sciimmunol.aay6125. PMID: 31672862.","DOI":"10.1126\/sciimmunol.aay6125"},{"key":"2283_CR53","unstructured":"CDC, Measles (Rubeola). Clinical overview of measles. https:\/\/www.cdc.gov\/measles\/hcp\/clinical-overview\/index.html. Accessed on 02.01.2026 CDC. Measles."},{"issue":"Suppl 3","key":"2283_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.11604\/pamj.supp.2017.27.3.12553","volume":"27","author":"R Davis","year":"2017","unstructured":"Davis R, Mbabazi WB. Challenges to global measles eradication: is it all in the timing? Pan Afr Med J. 2017;27(Suppl 3):11. https:\/\/doi.org\/10.11604\/pamj.supp.2017.27.3.12553. PMID: 29296146; PMCID: PMC5745928.","journal-title":"Pan Afr Med J"},{"issue":"5","key":"2283_CR55","first-page":"680","volume":"58","author":"AA Rabaan","year":"2022","unstructured":"Rabaan AA, Mutair AA, Alhumaid S, Garout M, Alsubki RA, Alshahrani FS, Alfouzan WA, Alestad JH, Alsaleh AE, Al-Mozaini MA, Koritala T, Alotaibi S, Temsah MH, Akbar A, Ahmad R, Khalid Z, Muhammad J, Ahmed N. Updates on Measles Incidence and Eradication: Emphasis on the Immunological Aspects of Measles Infection. Med (Kaunas). 2022;58(5):680.","journal-title":"Med (Kaunas)"},{"issue":"45","key":"2283_CR56","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.15585\/mmwr.mm7345a4","volume":"73","author":"AA Minta","year":"2024","unstructured":"Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Wimmer A, Bose AS, O\u2019Connor P, Crowcroft NS. Progress Toward Measles Elimination - Worldwide, 2000\u20132023. MMWR Morb Mortal Wkly Rep. 2024;73(45):1036\u201342. https:\/\/doi.org\/10.15585\/mmwr.mm7345a4. PMID: 39541251; PMCID: PMC11576049.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2283_CR57","doi-asserted-by":"publisher","first-page":"ofad032","DOI":"10.1093\/ofid\/ofad032","volume":"10","author":"ME Peck","year":"2023","unstructured":"Peck ME, Maleghemi S, Kayembe L, Hercules M, Anyuon A, Bunga S, McFarland J, Olu O. Nationwide Measles and Rubella Outbreaks in South Sudan, 2019. Open Forum Infect Dis. 2023;10(2):ofad032.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"2283_CR58","doi-asserted-by":"publisher","first-page":"e108786","DOI":"10.1371\/journal.pone.0108786","volume":"9","author":"AS Bose","year":"2014","unstructured":"Bose AS, Jafari H, Sosler S, Narula AP, Kulkarni VM, Ramamurty N, Oommen J, Jadi RS, Banpel RV, Henao-Restrepo AM. Case based measles surveillance in Pune: evidence to guide current and future measles control and elimination efforts in India. PLoS ONE. 2014;9(10):e108786.","journal-title":"PLoS ONE"},{"key":"2283_CR59","first-page":"55","volume":"1","author":"Z Kurug\u00f6l","year":"2007","unstructured":"Kurug\u00f6l Z, Oral A, Koturo\u00a4lu G, Akflit S. The Importance of Laboratory Confirmation in Measles Surveillance. J Pediatr Inf. 2007;1:55\u20137.","journal-title":"J Pediatr Inf"},{"issue":"2","key":"2283_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.vaccine.2017.07.066","volume":"37","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine. 2019;37(2):219\u201322. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.066. Epub 2017 Jul 29. PMID: 28760612.","journal-title":"Vaccine"},{"issue":"9","key":"2283_CR61","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3201\/eid3009.240150","volume":"30","author":"I Tranter","year":"2024","unstructured":"Tranter I, Smoll N, Lau CL, Williams DL, Neucom D, Barnekow D, Dyda A. Onward Virus Transmission after Measles Secondary Vaccination Failure. Emerg Infect Dis. 2024;30(9):1747\u201354. https:\/\/doi.org\/10.3201\/eid3009.240150. PMID: 39173667; PMCID: PMC11346981.","journal-title":"Emerg Infect Dis"},{"key":"2283_CR62","unstructured":"CDC, Measles Prevention. Recommendations of the immunization practices advisory committee (ACIP). https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00041753.htm?utm_source=chatgpt.com. Accessed on 24.12.2025."},{"key":"2283_CR63","unstructured":"CDC. Measles (Rubeola). Measles vaccine recommendations. Sept. 20. 2024. https:\/\/www.cdc.gov\/measles\/hcp\/vaccine-considerations\/index.html. Accessed on 23.12.2025."},{"key":"2283_CR64","volume-title":"Measles on the rise in the EU\/EEA: considerations for public health response. 16 February 2024","author":"European Centre for Disease Prevention and Control","year":"2024","unstructured":"European Centre for Disease Prevention and Control. Measles on the rise in the EU\/EEA: considerations for public health response. 16 February 2024. Stockholm: ECDC; 2024."},{"key":"2283_CR65","unstructured":"WHO. Measles SIAs planning & implementation field guide. 2010. https:\/\/s3.amazonaws.com\/wp-agility2\/measles\/wp-content\/uploads\/2017\/01\/WHO-AFRO-Measles-Fieldguide-April-2011.pdf?utm_source=chatgpt.com. Accessed on 25.12.2025."},{"key":"2283_CR66","unstructured":"Pan-American Health Organization (PAHO). Tag recommendations for measles. 2024. https:\/\/www.paho.org\/sites\/default\/files\/2025-01\/1999-2024-tag-recommendations-measles.pdf?utm_source=chatgpt.com. Accessed on 25.12.2025."},{"issue":"2","key":"2283_CR67","doi-asserted-by":"publisher","first-page":"2252681","DOI":"10.1080\/21645515.2023.2252681","volume":"19","author":"C Ferrari","year":"2023","unstructured":"Ferrari C, Somma G, Olesen O, Buonomo E, Pasanisi Zingarello M, Mazza A, Rizza S, Di Giampaolo L, Magrini A, Ponzani F, Coppeta L. Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era. Hum Vaccin Immunother. 2023;19(2):2252681.","journal-title":"Hum Vaccin Immunother"},{"key":"2283_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.29245\/2578-3009\/2018\/si.1121","volume":"Suppl","author":"B Masresha","year":"2018","unstructured":"Masresha B, Luce R, Shibeshi M, Katsande R, Fall A, Okeibunor J, Weldegebriel G, Mihigo R. Status of Measles Elimination in Eleven Countries with High Routine Immunisation Coverage in The WHO African Region. J Immunol Sci. 2018;Suppl:140\u20134.","journal-title":"J Immunol Sci"},{"key":"2283_CR69","unstructured":"CDC. Manual for the surveillance of vaccine-preventable diseases. Chapter 7: Measles. https:\/\/www.cdc.gov\/surv-manual\/php\/table-of-contents\/chapter-7-measles.html. Accessed on 31.12.2025."},{"issue":"12","key":"2283_CR70","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/vaccines12121349","volume":"12","author":"M Farid","year":"2024","unstructured":"Farid M, Fahmy K, Ghoniem A, Sharifuzzaman M, Hasan Q, Crowcroft N, O\u2019Connor P. Progress of Measles and Rubella Surveillance in the Context of Measles Elimination in the WHO Eastern Mediterranean Region, 2019\u20132022. Vaccines (Basel). 2024;12(12):1349. https:\/\/doi.org\/10.3390\/vaccines12121349. PMID: 39772011; PMCID: PMC11679470.","journal-title":"Vaccines (Basel)"},{"key":"2283_CR71","doi-asserted-by":"crossref","unstructured":"Bashir K, Wani KA, Qurieshi MA, Khan SMS, Haq I. Measles surveillance in Kashmir: a mixed methods study. Indian J Public Health. 2022 Jul-Sep;66(3):251\u20136.","DOI":"10.4103\/ijph.ijph_1482_21"},{"issue":"11","key":"2283_CR72","doi-asserted-by":"publisher","first-page":"e01472","DOI":"10.1128\/JCM.01472-20","volume":"58","author":"A Cui","year":"2020","unstructured":"Cui A, Wang H, Zhu Z, Mao N, Song J, Zhang Y, Xu W. Measles Vaccine-Associated Rash Illness in China: an Emerging Issue in the Process of Measles Elimination. J Clin Microbiol. 2020;58(11):e01472\u201320.","journal-title":"J Clin Microbiol"},{"key":"2283_CR73","doi-asserted-by":"publisher","unstructured":"Roose J, Rohaert C, Jadoul A, F\u00f6lster-Holst R, van Gysel D. Modified measles: a diagnostic challenge. Acta Derm Venereol. 2018;98(2):289\u2013290. https:\/\/doi.org\/10.2340\/00015555-2825. PMID: 29057422.","DOI":"10.2340\/00015555-2825"},{"issue":"12","key":"2283_CR74","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molmed.2015.10.005","volume":"21","author":"IH Haralambieva","year":"2015","unstructured":"Haralambieva IH, Kennedy RB, Ovsyannikova IG, Whitaker JA, Poland GA. Variability in Humoral Immunity to Measles Vaccine: New Developments. Trends Mol Med. 2015;21(12):789\u2013801.","journal-title":"Trends Mol Med"},{"key":"2283_CR75","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11262-011-0638-0","volume":"43","author":"J Shi","year":"2011","unstructured":"Shi J, Zheng J, Huang H, Hu Y, Bian J, Xu D, Li F. Measles incidence rate and a phylogenetic study of contemporary genotype H1 measles strains in China: is an improved measles vaccine needed? Virus Genes. 2011;43:319\u201326.","journal-title":"Virus Genes"},{"issue":"1","key":"2283_CR76","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41541-025-01088-y","volume":"10","author":"ME Emmelot","year":"2025","unstructured":"Emmelot ME, Bodewes R, Maissan C, Vos M, de Swart RL, van Els CACM, Kaaijk P. Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity. NPJ Vaccines. 2025;10(1):36.","journal-title":"NPJ Vaccines"},{"issue":"17","key":"2283_CR77","doi-asserted-by":"publisher","first-page":"11547","DOI":"10.1128\/JVI.79.17.11547-11551.2005","volume":"79","author":"RL de Swart","year":"2005","unstructured":"de Swart RL, Y\u00fcksel S, Osterhaus AD. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J Virol. 2005;79(17):11547\u201351.","journal-title":"J Virol"},{"key":"2283_CR78","doi-asserted-by":"publisher","unstructured":"Tahara M, B\u00fcrckert JP, Kanou K, Maenaka K, Muller CP, Takeda M. Measles virus hemagglutinin protein epitopes: the basis of antigenic stability. Viruses. 2016;8(8):216. https:\/\/doi.org\/10.3390\/v8080216. Erratum in: Viruses. 2016;8(11): E313.","DOI":"10.3390\/v8080216"},{"issue":"3","key":"2283_CR79","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.immuni.2025.02.006","volume":"58","author":"DP Maurer","year":"2025","unstructured":"Maurer DP, Vu M, Schmidt AG. Antigenic drift expands influenza viral escape pathways from recalled humoral immunity. Immunity. 2025;58(3):716\u2013e7276. https:\/\/doi.org\/10.1016\/j.immuni.2025.02.006. Epub 2025 Feb 28. PMID: 40023162; PMCID: PMC11906258.","journal-title":"Immunity"},{"issue":"9","key":"2283_CR80","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.celrep.2015.04.054","volume":"11","author":"BO Fulton","year":"2015","unstructured":"Fulton BO, Sachs D, Beaty SM, Won ST, Lee B, Palese P, Heaton NS. Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins. Cell Rep. 2015;11(9):1331\u20138.","journal-title":"Cell Rep"},{"issue":"2","key":"2283_CR81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jiph.2021.12.014","volume":"15","author":"JA Malik","year":"2022","unstructured":"Malik JA, Ahmed S, Mir A, Shinde M, Bender O, Alshammari F, Ansari M, Anwar S. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. J Infect Public Health. 2022;15(2):228\u201340.","journal-title":"J Infect Public Health"},{"issue":"1","key":"2283_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/JVI.73.1.51-54.1999","volume":"73","author":"SJ Schrag","year":"1999","unstructured":"Schrag SJ, Rota PA, Bellini WJ. Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol. 1999;73(1):51\u20134.","journal-title":"J Virol"},{"issue":"11","key":"2283_CR83","doi-asserted-by":"publisher","first-page":"e29184","DOI":"10.1002\/jmv.29184","volume":"95","author":"W Qu","year":"2023","unstructured":"Qu W, Sui L, Li Y. Vaccine escape challenges virus prevention: The example of two vaccine-preventable oncogenic viruses. J Med Virol. 2023;95(11):e29184.","journal-title":"J Med Virol"},{"issue":"21","key":"2283_CR84","doi-asserted-by":"publisher","first-page":"11546","DOI":"10.1128\/JVI.77.21.11546-11554.2003","volume":"77","author":"C Combredet","year":"2003","unstructured":"Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol. 2003;77(21):11546\u201354.","journal-title":"J Virol"},{"issue":"Suppl 1","key":"2283_CR85","doi-asserted-by":"publisher","first-page":"S533","DOI":"10.1093\/infdis\/jir097","volume":"204","author":"B Bankamp","year":"2011","unstructured":"Bankamp B, Takeda M, Zhang Y, Xu W, Rota PA. Genetic characterization of measles vaccine strains. J Infect Dis. 2011;204(Suppl 1):S533\u201348.","journal-title":"J Infect Dis"},{"issue":"4","key":"2283_CR86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/v8040109","volume":"8","author":"SM Beaty","year":"2016","unstructured":"Beaty SM, Lee B. Constraints on the Genetic and Antigenic Variability of Measles Virus. Viruses. 2016;8(4):109.","journal-title":"Viruses"},{"key":"2283_CR87","volume-title":"Immunization Safety Review Committee. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism","year":"2001","unstructured":"Institute of Medicine (US). In: Stratton K, Gable A, Shetty P, McCormick M, editors. Immunization Safety Review Committee. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington (DC): National Academies Press (US); 2001."},{"issue":"4","key":"2283_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/vaccines7040199","volume":"7","author":"M Pacenti","year":"2019","unstructured":"Pacenti M, Maione N, Lavezzo E, Franchin E, Dal Bello F, Gottardello L, Barzon L. Measles Virus Infection and Immunity in a Suboptimal Vaccination Coverage Setting. Vaccines (Basel). 2019;7(4):199.","journal-title":"Vaccines (Basel)"},{"issue":"10111","key":"2283_CR89","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","volume":"390","author":"WJ Moss","year":"2017","unstructured":"Moss WJ, Measles. 10.1016\/S0140-6736(17)31463-0. Lancet. 2017;390(10111):2490\u2013502. Epub 2017 Jun 30. PMID: 28673424.","journal-title":"Lancet"},{"issue":"9","key":"2283_CR90","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s10096-019-03604-0","volume":"38","author":"P Plans-Rubi\u00f3","year":"2019","unstructured":"Plans-Rubi\u00f3 P. Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017\u20132018. Eur J Clin Microbiol Infect Dis. 2019;38(9):1719\u201329.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"2283_CR91","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3947\/ic.2019.51.3.305","volume":"51","author":"JW Park","year":"2019","unstructured":"Park JW, Yu SN, Park E, Lee Y, Park SM, Jeon MH. Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine. Infect Chemother. 2019;51(3):305\u20139.","journal-title":"Infect Chemother"},{"issue":"3","key":"2283_CR92","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/vaccines7030118","volume":"7","author":"H Sasaki","year":"2019","unstructured":"Sasaki H, Fukunaga T, Asano A, Suzuki Y, Nakanishi Y, Kondo J, Ishikawa H, Shibata N. A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults. Vaccines (Basel). 2019;7(3):118.","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"2283_CR93","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.infpip.2019.100018","volume":"1","author":"L Berry","year":"2019","unstructured":"Berry L, Palmer T, Wells F, Williams E, Sibal B, Timms J. Nosocomial outbreak of measles amongst a highly vaccinated population in an English hospital setting. Infect Prev Pract. 2019;1(2):100018.","journal-title":"Infect Prev Pract"},{"key":"2283_CR94","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhao Y, Yang L, Lu C, Meng Y, Guan X, An H, Zhang M, Guo W, Shang B, Yu J. Measles outbreak among previously immunized adult healthcare workers, China, 2015. Can J Infect Dis Med Microbiol. 2016;1742530.","DOI":"10.1155\/2016\/1742530"},{"issue":"8","key":"2283_CR95","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/jmv.25665","volume":"92","author":"N Madi","year":"2020","unstructured":"Madi N, Altawalah H, Alfouzan W, Al-Nakib W, Al-Roumi E, Jeragh A. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy. J Med Virol. 2020;92(8):963\u201370.","journal-title":"J Med Virol"},{"key":"2283_CR96","doi-asserted-by":"publisher","unstructured":"Al-Rawahi B, Patel P, Al-Farsi N, Al-Kindi H, Al-Jardani A, Al-Shukri I, Al-Mahruqi S, fseroprevalence in Oman. East Mediterr Health J. 2025;31(1):30\u201336. https:\/\/doi.org\/10.26719\/2025.31.1.30. PMID: 39945183.","DOI":"10.26719\/2025.31.1.30"},{"issue":"3","key":"2283_CR97","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1017\/s002217240006160x","volume":"94","author":"RM Anderson","year":"1985","unstructured":"Anderson RM, May RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg (Lond). 1985;94(3):365\u2013436. https:\/\/doi.org\/10.1017\/s002217240006160x. PMID: 4008922; PMCID: PMC2129492.","journal-title":"J Hyg (Lond)"},{"issue":"13","key":"2283_CR98","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2017.9984","volume":"318","author":"NS Clemmons","year":"2017","unstructured":"Clemmons NS, Wallace GS, Patel M, Gasta\u00f1aduy PA. Incidence of Measles in the United States, 2001\u20132015. JAMA. 2017;318(13):1279\u201381. https:\/\/doi.org\/10.1001\/jama.2017.9984. PMID: 28973240; PMCID: PMC5727570.","journal-title":"JAMA"},{"key":"2283_CR99","unstructured":"CDC. Measles Update \u2014 United States, January 1\u2013April 17. 2025. https:\/\/www.cdc.gov\/mmwr\/volumes\/74\/wr\/mm7414a1.htm?utm_source=chatgpt.com. Accessed on 01.01.2026."},{"issue":"6","key":"2283_CR100","doi-asserted-by":"publisher","first-page":"e66771","DOI":"10.1371\/journal.pone.0066771","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu Y, Lu P, Hu Y, Wang Z, Deng X, Ma F, Tao H, Jia C, Ding X, Yang H, Liu P, Min J. Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children. PLoS ONE. 2013;8(6):e66771. https:\/\/doi.org\/10.1371\/journal.pone.0066771. PMID: 23825562; PMCID: PMC3692513.","journal-title":"PLoS ONE"},{"key":"2283_CR101","doi-asserted-by":"publisher","unstructured":"Betta Ragazzi SL, De Andrade Vaz-de-Lima LR, Rota P, Bellini WJ, Gilio AE, Costa Vaz FA, Durigon EL. Congenital and neonatal measles during an epidemic in S\u00e3o Paulo, Brazil in 1997. Pediatr Infect Dis J. 2005;24(4):377-8. https:\/\/doi.org\/10.1097\/01.inf.0000157220.00454.24. PMID: 15818302.","DOI":"10.1097\/01.inf.0000157220.00454.24"},{"issue":"1","key":"2283_CR102","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/JCMA.0000000000000210","volume":"83","author":"HL Chen","year":"2020","unstructured":"Chen HL, Tang RB. Measles re-emerges and recommendation of vaccination. J Chin Med Assoc. 2020;83(1):5\u20137.","journal-title":"J Chin Med Assoc"},{"key":"2283_CR103","doi-asserted-by":"publisher","first-page":"1521602","DOI":"10.3389\/fpubh.2025.1521602","volume":"13","author":"ET Abeje","year":"2025","unstructured":"Abeje ET, Enyew EB, Daba C, Asmare L, Bayou FD, Arefaynie M, Mohammed A, Tareke AA, Keleb A, Kebede N, Tsega Y, Endawkie A, Kebede SD, Abera KM. Time to first dose of measles-containing vaccine and associated factors among infants in Ethiopia: a survival analysis from performance monitoring for action data. Front Public Health. 2025;13:1521602. https:\/\/doi.org\/10.3389\/fpubh.2025.1521602. PMID: 41179775; PMCID: PMC12571857.","journal-title":"Front Public Health"},{"key":"2283_CR104","doi-asserted-by":"publisher","first-page":"1546253","DOI":"10.3389\/fimmu.2025.1546253","volume":"16","author":"S Buus","year":"2025","unstructured":"Buus S, Vittrup DM, Schmidt JD, Jensen A, Stryhn A, Stensballe LG. Measles-mumps-rubella-vaccination at 6 months of age induces measles-specific T cell responses: a randomized controlled trial. Front Immunol. 2025;16:1546253. https:\/\/doi.org\/10.3389\/fimmu.2025.1546253. PMID: 40165977; PMCID: PMC11955646.","journal-title":"Front Immunol"},{"key":"2283_CR105","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1743-422X-7-87","volume":"7","author":"H Zhao","year":"2010","unstructured":"Zhao H, Lu PS, Hu Y, Wu Q, Yao W, Zhou YH. Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination. Virol J. 2010;7:87.","journal-title":"Virol J"},{"key":"2283_CR106","doi-asserted-by":"publisher","unstructured":"Capasso L, Lepore L, Lo Vecchio A, Caprio MG, Vallone G, Raimondi F. An old disease comes back: reporting 2 cases of neonatal measles. J Pediatric Infect Dis Soc. 2021;10(2):155\u2013156. https:\/\/doi.org\/10.1093\/jpids\/piz067. PMID: 31603509.","DOI":"10.1093\/jpids\/piz067"},{"key":"2283_CR107","doi-asserted-by":"publisher","unstructured":"Mutembo S, Yang Y, Carcelen A, Winter AK, Mwansa FD, Chilumba I, Mutale I, Chongwe G, Monze M, Mulundu G, Nkamba H, Mulenga L, Hayford K, Moss WJ. Measles immunity gaps among children and adolescents with HIV in Zambia despite high measles vaccination and antiretroviral therapy coverage. AIDS. 2023;37(13):2021\u20132029. https:\/\/doi.org\/10.1097\/QAD.0000000000003634. Epub 2023 Jun 28. PMID: 37418463; PMCID: PMC10664789. 107. Mutembo 2023,108.","DOI":"10.1097\/QAD.0000000000003634"},{"issue":"4","key":"2283_CR108","doi-asserted-by":"publisher","first-page":"e0003954","DOI":"10.1371\/journal.pgph.0003954","volume":"5","author":"PN Gardner","year":"2025","unstructured":"Gardner PN, Hangoma J, Sialubanje C, Chipoya M, Lamba L, Mwenechanya M, Chilyabanyama R, Kasonde M, Simwaba D, Kapina M, Young S, Mwangilwa K, Chilengi R, Fwemba I. Factors associated with measles vaccine immunogenicity in children at University Teaching Hospitals, Lusaka, Zambia. PLOS Glob Public Health. 2025;5(4):e0003954. https:\/\/doi.org\/10.1371\/journal.pgph.0003954. PMID: 40267112; PMCID: PMC12017566.","journal-title":"PLOS Glob Public Health"},{"key":"2283_CR109","doi-asserted-by":"publisher","unstructured":"Moss WJ, Cutts F, Griffin DE. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis. 1999;29(1):106\u2009\u2013\u200912. https:\/\/doi.org\/10.1086\/520136. PMID: 10433572.","DOI":"10.1086\/520136"},{"key":"2283_CR110","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eclinm.2018.06.002","volume":"1","author":"EAML Mutsaerts","year":"2018","unstructured":"Mutsaerts EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, Grobbee DE, Madhi SA. Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis. EClinicalMedicine. 2018;1:28\u201342. PMID: 31193646; PMCID: PMC6537570.","journal-title":"EClinicalMedicine"},{"key":"2283_CR111","unstructured":"CDC. Vaccine safety. Measles, Mumps, Rubella (MMR) vaccine safety. 31, 2024. https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/mmr.html. Accessed On 25.12.2025."},{"key":"2283_CR112","doi-asserted-by":"publisher","unstructured":"Gbenewei E, Nomhwange T, Taiwo L, Ayodeji I, Yusuf K, Jean Baptiste AE, Nsubuga P, Braka F, Oteri J, Shuaib F. Adverse events following immunization: findings from 2017\/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017\/2018 measles vaccination campaign. Vaccine. 2021;39 Suppl 3:C82-C88. https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.067. Epub 2021 Mar 11. PMID: 33714655.","DOI":"10.1016\/j.vaccine.2021.02.067"},{"key":"2283_CR113","first-page":"81","volume":"40","author":"OO Malande","year":"2021","unstructured":"Malande OO, Munube D, Afaayo RN, Chemweno C, Nzoka M, Kipsang J, Musyoki AM, Meyer JC, Omayo LN, Owino-Okongo L. Adverse events following immunization reporting and impact on immunization services in informal settlements in Nairobi, Kenya: a prospective mixed-methods study. Pan Afr Med J. 2021;40:81. PMID: 34909070; PMCID: PMC8607951.","journal-title":"Pan Afr Med J"},{"issue":"10","key":"2283_CR114","doi-asserted-by":"publisher","first-page":"e1363","DOI":"10.1016\/S2214-109X(22)00388-6","volume":"10","author":"PL Raghunathan","year":"2022","unstructured":"Raghunathan PL, Orenstein W. Investing in global measles and rubella elimination is needed to avert deaths and advance health equity. Lancet Glob Health. 2022;10(10):e1363\u20134.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"2283_CR115","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/aje\/kwv320","volume":"184","author":"RA Bednarczyk","year":"2016","unstructured":"Bednarczyk RA, Orenstein WA, Omer SB. Estimating the Number of Measles-Susceptible Children and Adolescents in the United States Using Data from the National Immunization Survey-Teen (NIS-Teen). Am J Epidemiol. 2016;184(2):148\u201356.","journal-title":"Am J Epidemiol"},{"key":"2283_CR116","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1016\/j.vaccine.2008.08.074","volume":"26","author":"B Cohen","year":"2008","unstructured":"Cohen B, Doblas D, Andrews N. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine. 2008;26:6392\u20137.","journal-title":"Vaccine"},{"key":"2283_CR117","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/cid\/ciz363","volume":"70","author":"KB Gibney","year":"2020","unstructured":"Gibney KB, Attwood LO, Nicholson S, Tran T, Druce J, Healy J, Strachan J, Franklin L, Hall R, Cross GB. Emergence of attenuated measles illness among IgG-positive\/IgM-negative measles cases, Victoria, Australia 2008\u20132017. Clin Infect Dis. 2020;70:1060\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2283_CR118","doi-asserted-by":"publisher","first-page":"e0208161","DOI":"10.1371\/journal.pone.0208161","volume":"13","author":"A Cui","year":"2018","unstructured":"Cui A, Mao N, Wang H, Xu S, Zhu Z, Ji Y, Ren L, Gao L, Zhang Y, Xu W. Importance of real-time RT-PCR to supplement the laboratory diagnosis in the measles elimination program in China. PLoS ONE. 2018;13(11):e0208161.","journal-title":"PLoS ONE"},{"key":"2283_CR119","doi-asserted-by":"crossref","unstructured":"Uren AM, Vasant BR, Judd D, Looke DFM, Henderson AJ, Jarvinen KAJ. Modified measles with an atypical presentation. Commun Dis Intell (2018). 2019;43.","DOI":"10.33321\/cdi.2019.43.26"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02283-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02283-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02283-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:03:22Z","timestamp":1786532602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-026-02283-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02283-w","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a review article and does not need ethical approvals.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agreed to publish this review article in Italian Journal of Pediatrics.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}